Edition:
United Kingdom

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

6.10USD
22 Jan 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.10
Open
$6.14
Day's High
$6.14
Day's Low
$6.02
Volume
3,174
Avg. Vol
34,677
52-wk High
$15.00
52-wk Low
$3.60

Select another date:

Mon, Dec 4 2017

BRIEF-Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​

* APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​ Source text (http://bit.ly/2AONduG) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System

* APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM

BRIEF-David Pacitti joins Apollo Endosurgery board of directors

* David C. Pacitti joins Apollo Endosurgery board of directors

BRIEF-Apollo Endosurgery reports qtrly loss per share $‍0.32​

* Apollo Endosurgery Inc - qtrly loss per share $‍0.32​ Source text for Eikon: Further company coverage:

BRIEF-Apollo endosurgery announces CE mark approval for the Orbera365™ managed weight loss system,

* Apollo Endosurgery announces CE mark approval for the Orbera365™ managed weight loss system, expanding the indwell period from 6 months to 12 months with the gastric balloon category leader

BRIEF-Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc

* Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc as of August 11, 2017 - SEC filing‍​ Source text: (http://bit.ly/2xbQJty) Further company coverage:

BRIEF-Novo Holdings A/S reports 3.9 pct stake in Apollo Endosurgery as on Aug 14

* Novo Holdings A/S reports 3.9 percent stake in Apollo Endosurgery Inc as on August 14, 2017 - SEC filing‍​

BRIEF-Apollo Endosurgery Q2 revenue $17.1 mln

* Apollo Endosurgery - total endo-bariatric revenues were $9.5 million for three months ended june 30, 2017, an increase of 13.0% compared to q2 of 2016

Select another date: